BAYER

Carsten Brunn to Lead Bayer’s Pharmaceuticals Business in the Americas Region

 

Dr. Carsten Brunn
Bayer (a DiversityInc Noteworthy Company) has announced the appointment of Dr. Carsten Brunnas as president of its pharmaceuticals business in the Americas, comprising the United States, Canada, Central and Latin America. In this role, Dr. Brunn will report to Dieter Weinand, member of the board of management of Bayer AG and President of the Pharmaceutical division.

“Carsten is a strategic and highly respected leader in the pharmaceutical industry and I’m delighted to have him lead the company’s largest pharmaceutical business worldwide,” saidDieter Weinand. “Carsten’s global perspective and proven track record of successful operational execution at the local level will be a critical asset to us as we continue to build on our current momentum in the U.S. and across the Americas region.”

Previously, Dr. Brunn was head of Bayer’s pharmaceuticals commercial operations inJapan, a role he held since 2013. He served as the chairman of European Federation of Pharmaceutical Industries and Associations (EFPIA) Japan, an organization representing 24 R&D-based innovative pharmaceutical companies in Japan. Dr. Brunn joined Bayer in 2011 as Global Head of Primary Care based in Beijing, China. Prior to joining Bayer, Dr. Brunn held a number of senior leadership roles at companies including Eli Lilly, Novartis, and Bausch & Lomb in Europe, Asia, and the United States.

“It has been an incredibly rewarding experience to lead Bayer’s pharmaceuticals organization in Japan, and I am honored to have the opportunity to join such an established team here in the United States,” said Carsten Brunn. “The U.S. is one of the most important and innovative pharmaceutical markets in the world, where we are in a solid period of consistent growth with strong performance across all our therapeutic areas. I’m thrilled to bring my experiences from other markets to this organization as we continue to build on our strengths and meet the needs of patients.”

Dr. Brunn graduated from the University of Freiburg in Germany with a Master of Science in Pharmaceutical Science. In addition, he studied at the University of Washington under a research scholarship and later received his PhD in Chemistry from the University of Hamburg in Germany. He completed his executive education at theLondon Business School.

Latest News

Increasing Response to Pandemic, Toyota Partners with American Safety Company Bullard

Originally published on pressroom.toyota.com. Toyota Production System key to ramping up production in warp speed, providing critical items to healthcare workers Toyota-Bullard team applied TPS to produce faceshields, respirators, hoods Eliminated backlog of faceshield orders; 700-percent increase in output from March to April Doubled production capacity for respirators; 85-percent faster…

nielsen

Nielsen Reinforces Leadership in Pet Retail Through Expansion of Store Coverage

Nielsen (NYSE: NLSN) Global Connect today announced the enhancement of its Nielsen Total U.S. Pet Retail measurement, strengthening the industry’s most holistic view into the U.S. pet retail market. Already measuring more than $30 billion in annual sales of pet products, Nielsen will further enhance its coverage of the growing neighborhood pet channel and more frequently update its best-in-class retail universe.

Hershey’s Joins Jet-Puffed and Honey Maid Brands Make National S’mores Day Extra Sweet By Giving Back $50,000 To Small, Local Restaurants

Originally published on thehersheycompany.com. Summer screams S’mores, but this year it is screaming louder than ever with approximately 10M more of the classic treat made this year compared to last1. With many of America’s beloved restaurants closed due to quarantine orders or limited in capacity due to social distancing, Americans…

Humana

Humana Ranks #1 for Customer Satisfaction for Mail Order in J.D. Power Pharmacy Study for Third Year in a Row

Originally published on Humana.com.  LOUISVILLE, Ky.–(BUSINESS WIRE)– Humana Pharmacy, a division of Humana Inc. (NYSE: HUM), has been named the best in Mail Order Pharmacy customer satisfaction in the J.D. Power 2020 U.S. Pharmacy Study. It’s the third consecutive year that Humana has received the prestigious honor. The study ranks…

California, board, corporate, directors

California Bill Would Mandate Racial Diversity on Corporate Boards

A recent California bill would mandate diversity in corporate boards for all companies headquartered within the state. The bill would ban all-white corporate boards and comes on the heels of a 2018 law that mandated women hold seats in all corporate boards. This racial diversity bill AB 979 defines “underrepresented…